|
LSTA Lisata Therapeutics Inc 320017 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-2,929,000.00 |
| Balance Sheet |
|
Current Assets
|
$11,013,000.00 |
|
Assets
|
$11,027,000.00 |
|
Current Liabilities
|
$2,987,000.00 |
|
Liabilities
|
$3,037,000.00 |
|
Equity
|
$8,244,000.00 |
|
Shares Out
|
9119004.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,732,000.00 |
| Market Analysis |
Market Cap
|
$10,213,284.48 |
|
Price
|
$1.12 |
|
BVPS
|
0.90 |
|
PB
|
1.24 |
|
EPS
|
-0.32 |
|
FCF
|
$-5,732,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:47 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-1.91 |
|
|
2026-05-11 |
-0.50 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.54 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.49 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view LSTA documents filed with the SEC.
LSTA Filings
Clear
